Prakhar Agrawal
Stock Analyst at Cantor Fitzgerald
(4.23)
# 1,457
Out of 4,587 analysts
119
Total ratings
39.5%
Success rate
14.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Prakhar Agrawal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IVA Inventiva | Initiated Coverage: Buy | n/a | $4.62 | - | 1 | Jul 17, 2026 | |
| SLN Silence Therapeutics | Initiated Coverage: Buy | n/a | $11.62 | - | 1 | Jun 24, 2026 | |
| GPCR Structure Therapeutics | Maintained: Buy | $101 | $49.47 | +104.16% | 10 | Jun 7, 2026 | |
| STTK Shattuck Labs | Initiated Coverage: Buy | n/a | $7.19 | - | 1 | Apr 27, 2026 | |
| ZLDPF Zealand Pharma A/S | Downgraded: Hold | n/a | $46.53 | - | 4 | Mar 6, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | n/a | $104.63 | - | 1 | Mar 1, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | n/a | $57.28 | - | 7 | Feb 20, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | n/a | $18.99 | - | 9 | Dec 4, 2025 | |
| EVMN Evommune | Initiated Coverage: Buy | n/a | $11.35 | - | 1 | Dec 1, 2025 | |
| MDGL Madrigal Pharmaceuticals | Upgraded: Buy | n/a | $493.11 | - | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.32 | - | 2 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.64 | - | 6 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.48 | - | 10 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $19.39 | - | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.04 | n/a | 1 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $34.52 | n/a | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $87.32 | n/a | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $53.53 | n/a | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.22 | n/a | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $2.8 | $2.32 | n/a | 10 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.32 | n/a | 2 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $3.5 | $1.88 | n/a | 3 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $23 | $3.84 | n/a | 8 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $62 | $9.03 | n/a | 8 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 | $27.99 | n/a | 8 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.60 | n/a | 8 | Aug 5, 2021 |
Inventiva
Jul 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $4.62
Upside: -
Silence Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $11.62
Upside: -
Structure Therapeutics
Jun 7, 2026
Maintained: Buy
Price Target: $101
Current: $49.47
Upside: +104.16%
Shattuck Labs
Apr 27, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $7.19
Upside: -
Zealand Pharma A/S
Mar 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $46.53
Upside: -
Veradermics
Mar 1, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $104.63
Upside: -
Travere Therapeutics
Feb 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $57.28
Upside: -
MoonLake Immunotherapeutics
Dec 4, 2025
Maintained: Buy
Price Target: n/a
Current: $18.99
Upside: -
Evommune
Dec 1, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $11.35
Upside: -
Madrigal Pharmaceuticals
Nov 4, 2025
Upgraded: Buy
Price Target: n/a
Current: $493.11
Upside: -
Oct 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $5.32
Upside: -
Sep 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $11.64
Upside: -
Sep 15, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.48
Upside: -
Aug 15, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $19.39
Upside: -
Jul 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $5.04
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $34.52
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $87.32
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: n/a
Current: $53.53
Upside: n/a
Jan 21, 2025
Downgraded: Hold
Price Target: n/a
Current: $10.22
Upside: n/a
Aug 11, 2023
Maintained: Buy
Price Target: $14 → $2.8
Current: $2.32
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $4.32
Upside: n/a
Jan 10, 2023
Maintained: Buy
Price Target: $5 → $3.5
Current: $1.88
Upside: n/a
Sep 12, 2022
Maintained: Buy
Price Target: $27 → $23
Current: $3.84
Upside: n/a
Oct 18, 2021
Maintained: Buy
Price Target: $58 → $62
Current: $9.03
Upside: n/a
Sep 21, 2021
Maintained: Buy
Price Target: $44
Current: $27.99
Upside: n/a
Aug 5, 2021
Maintained: Buy
Price Target: $22
Current: $1.60
Upside: n/a